NF-κB (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "NF-κB" in Italian language version.

refsWebsite

Global rank Italian rank

13nih.gov

4^th place

9^th place

7oadoi.org

799^th place

22^nd place

7doi.org

2^nd place

7^th place

2web.archive.org

1^st place

1jimmunol.org

low place

doi.org (Global: 2^nd place; Italian: 7^th place)

dx.doi.org

TD. Gilmore, The Rel/NF-κB signal transduction pathway: introduction., in Oncogene, vol. 18, n. 49, novembre 1999, pp. 6842-4, DOI:10.1038/sj.onc.1203237, PMID 10602459.
BC. Albensi, MP. Mattson, Evidence for the involvement of TNF and NF-κB in hippocampal synaptic plasticity., in Synapse, vol. 35, n. 2, febbraio 2000, pp. 151-9, DOI:10.1002/(SICI)1098-2396(200002)35:2151::AID-SYN83.0.CO;2-P, PMID 10611641.
R. Sen, D. Baltimore, Multiple nuclear factors interact with the immunoglobulin enhancer sequences., in Cell, vol. 46, n. 5, agosto 1986, pp. 705-16, DOI:10.1016/0092-8674(86)90346-6, PMID 3091258.
Garg A, Aggarwal BB, Nuclear transcription factor-kappaB as a target for cancer drug development, in Leukemia, vol. 16, n. 6, giugno 2002, pp. 1053-68, DOI:10.1038/sj.leu.2402482, PMID 12040437.
Sethi G, Sung B, Aggarwal BB, Nuclear factor-kappaB activation: from bench to bedside, in Exp. Biol. Med. (Maywood), vol. 233, n. 1, gennaio 2008, pp. 21-31, DOI:10.3181/0707-MR-196, PMID 18156302.
Hamdy NA, Denosumab: RANKL inhibition in the management of bone loss, in Drugs Today (Barc)., vol. 44, n. 1, 2008, pp. 7-21, DOI:10.1358/dot.2008.44.1.1178467, PMID 18301800.
Cvek B, Dvorak Z, Targeting of nuclear factor-κB and proteasome by dithiocarbamate complexes with metals, in Curr. Pharm. Des., vol. 13, n. 30, 2007, pp. 3155-67, DOI:10.2174/138161207782110390, PMID 17979756.

jimmunol.org (Global: low place; Italian: low place)

(EN) S. P. Hehner, T. G. Hofmann, W. Dröge and M. Lienhard Schmitz, The Antiinflammatory Sesquiterpene Lactone Parthenolide Inhibits NF-κB by Targeting the IκB Kinase Complex, in The Journal of Immunology, vol. 163, n. 10, 1999, pp. 5617-5623. PDF

nih.gov (Global: 4^th place; Italian: 9^th place)

ncbi.nlm.nih.gov

TD. Gilmore, The Rel/NF-κB signal transduction pathway: introduction., in Oncogene, vol. 18, n. 49, novembre 1999, pp. 6842-4, DOI:10.1038/sj.onc.1203237, PMID 10602459.
BC. Albensi, MP. Mattson, Evidence for the involvement of TNF and NF-κB in hippocampal synaptic plasticity., in Synapse, vol. 35, n. 2, febbraio 2000, pp. 151-9, DOI:10.1002/(SICI)1098-2396(200002)35:2151::AID-SYN83.0.CO;2-P, PMID 10611641.
R. Sen, D. Baltimore, Multiple nuclear factors interact with the immunoglobulin enhancer sequences., in Cell, vol. 46, n. 5, agosto 1986, pp. 705-16, DOI:10.1016/0092-8674(86)90346-6, PMID 3091258.
(EN) NFKB1 nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 [Homo sapiens] - Gene - NCBI, su ncbi.nlm.nih.gov.
(EN) NFKB2 nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) [Homo sapiens] - Gene - NCBI, su ncbi.nlm.nih.gov.
(EN) RELA v-rel reticuloendotheliosis viral oncogene homolog A (avian) [Homo sapiens] - Gene - NCBI, su ncbi.nlm.nih.gov.
(EN) RELB v-rel reticuloendotheliosis viral oncogene homolog B [Homo sapiens] - Gene - NCBI, su ncbi.nlm.nih.gov.
(EN) REL v-rel reticuloendotheliosis viral oncogene homolog (avian) [Homo sapiens] - Gene - NCBI, su ncbi.nlm.nih.gov.
Garg A, Aggarwal BB, Nuclear transcription factor-kappaB as a target for cancer drug development, in Leukemia, vol. 16, n. 6, giugno 2002, pp. 1053-68, DOI:10.1038/sj.leu.2402482, PMID 12040437.
Sethi G, Sung B, Aggarwal BB, Nuclear factor-kappaB activation: from bench to bedside, in Exp. Biol. Med. (Maywood), vol. 233, n. 1, gennaio 2008, pp. 21-31, DOI:10.3181/0707-MR-196, PMID 18156302.
Vlahopoulos S, Boldogh I, Casola A, Brasier AR, Nuclear factor-κB-dependent induction of interleukin-8 gene expression by tumor necrosis factor alpha: evidence for an antioxidant sensitive activating pathway distinct from nuclear translocation, in Blood, vol. 94, n. 6, settembre 1999, pp. 1878-89, PMID 10477716. URL consultato il 24 aprile 2012 (archiviato dall'url originale il 12 settembre 2019).
Hamdy NA, Denosumab: RANKL inhibition in the management of bone loss, in Drugs Today (Barc)., vol. 44, n. 1, 2008, pp. 7-21, DOI:10.1358/dot.2008.44.1.1178467, PMID 18301800.
Cvek B, Dvorak Z, Targeting of nuclear factor-κB and proteasome by dithiocarbamate complexes with metals, in Curr. Pharm. Des., vol. 13, n. 30, 2007, pp. 3155-67, DOI:10.2174/138161207782110390, PMID 17979756.

oadoi.org (Global: 799^th place; Italian: 22^nd place)

TD. Gilmore, The Rel/NF-κB signal transduction pathway: introduction., in Oncogene, vol. 18, n. 49, novembre 1999, pp. 6842-4, DOI:10.1038/sj.onc.1203237, PMID 10602459.
BC. Albensi, MP. Mattson, Evidence for the involvement of TNF and NF-κB in hippocampal synaptic plasticity., in Synapse, vol. 35, n. 2, febbraio 2000, pp. 151-9, DOI:10.1002/(SICI)1098-2396(200002)35:2151::AID-SYN83.0.CO;2-P, PMID 10611641.
R. Sen, D. Baltimore, Multiple nuclear factors interact with the immunoglobulin enhancer sequences., in Cell, vol. 46, n. 5, agosto 1986, pp. 705-16, DOI:10.1016/0092-8674(86)90346-6, PMID 3091258.
Garg A, Aggarwal BB, Nuclear transcription factor-kappaB as a target for cancer drug development, in Leukemia, vol. 16, n. 6, giugno 2002, pp. 1053-68, DOI:10.1038/sj.leu.2402482, PMID 12040437.
Sethi G, Sung B, Aggarwal BB, Nuclear factor-kappaB activation: from bench to bedside, in Exp. Biol. Med. (Maywood), vol. 233, n. 1, gennaio 2008, pp. 21-31, DOI:10.3181/0707-MR-196, PMID 18156302.
Hamdy NA, Denosumab: RANKL inhibition in the management of bone loss, in Drugs Today (Barc)., vol. 44, n. 1, 2008, pp. 7-21, DOI:10.1358/dot.2008.44.1.1178467, PMID 18301800.
Cvek B, Dvorak Z, Targeting of nuclear factor-κB and proteasome by dithiocarbamate complexes with metals, in Curr. Pharm. Des., vol. 13, n. 30, 2007, pp. 3155-67, DOI:10.2174/138161207782110390, PMID 17979756.

web.archive.org (Global: 1^st place; Italian: 1^st place)

Vlahopoulos S, Boldogh I, Casola A, Brasier AR, Nuclear factor-κB-dependent induction of interleukin-8 gene expression by tumor necrosis factor alpha: evidence for an antioxidant sensitive activating pathway distinct from nuclear translocation, in Blood, vol. 94, n. 6, settembre 1999, pp. 1878-89, PMID 10477716. URL consultato il 24 aprile 2012 (archiviato dall'url originale il 12 settembre 2019).
Role of RCP006 as an anti-inflammatory agent, su rfdn.org, Roskamp Institute. URL consultato il 6 settembre 2011 (archiviato dall'url originale il 23 ottobre 2011).

NF-κB (Italian Wikipedia)

doi.org (Global: 2nd place; Italian: 7th place)